While automated insulin delivery (AID) systems improve the lives of many people with diabetes, there is a significant accessibility gap. Open-source AID systems can bridge this gap, says diabetologist Inge Van Boxelaer. Open-source AID systems have been shown to be as safe and effective as respective commercial systems, says Van Boxelaer, emphasising also the open-source community’s commitment to innovation. 


Literature mentioned in the episode:  
Burnside MJ, Lewis DM, Crocket HR, Meier RA, Williman JA, Sanders OJ, Jefferies CA, Faherty AM, Paul RG, Lever CS, Price SKJ, Frewen CM, Jones SD, Gunn TC, Lampey C, Wheeler BJ, de Bock MI. Open-Source Automated Insulin Delivery in Type 1 Diabetes. N Engl J Med. 2022 Sep 8;387(10):869-881. doi: 10.1056/NEJMoa2203913.